Merck’s Gardasil Adds Serotypes; Boosting Vaccinations Seems Bigger Challenge

Promotion strategy likely to remain same after nine-valent HPV vaccine wins FDA approval; Merck may need help from the CDC to overcome cultural barriers to adoption.